ConductScience.org, home

Paper415661

Sensitive bioassay for vancomycin.

Walker CA and 1 other. Antimicrob Agents Chemother, 1978. Cited by 50 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Sensitive bioassay for vancomycin. Papers, record 415661. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/415661

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sensitive bioassay for vancomycin.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
2.51
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Walker CAC A
2Kopp BB

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
VancomycinMajor topic
Adult
Biological Assay
Body Fluids
Female
Humans
Immunodiffusion

Source PubMed

References2

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
113,928,813Ototoxicity of neomycin and other antibiotics.J Laryngol Otol1962https://conductscience.org/library/papers/13928813PubMed
25,142,052Prevention of staphylococcal shunt infections by continuous vancomycin prophylaxis.Am J Med Sci1971https://conductscience.org/library/papers/5142052PubMed

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
39,766,523Therapeutic Monitoring of Vancomycin Implemented by Eremomycin ELISA.Antibiotics (Basel)2024https://conductscience.org/library/papers/39766523PubMed
36,364,147An Overview of Analytical Methodologies for Determination of Vancomycin in Human Plasma.Molecules2022https://conductscience.org/library/papers/36364147PubMed
31,713,055Does oral vancomycin use necessitate therapeutic drug monitoring?Infection2020https://conductscience.org/library/papers/31713055PubMed
22,848,719Synergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.PLoS One2012https://conductscience.org/library/papers/22848719PubMed
9,306,605Oral vancomycin hydrochloride therapy for postoperative methicillin-cephem-resistant Staphylococcus aureus enteritis.Surg Today1997https://conductscience.org/library/papers/9306605PubMed
7,325,638Comparison of vancomycin disposition in rats with normal and abnormal renal functions.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7325638PubMed
7,247,352Sensitive radioimmunoassay for vancomycin.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7247352PubMed
6,772,095Bioassay for determination of vancomycin in the presence of rifampin or aminoglycosides.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6772095PubMed
6,703,678Concentrations of vancomycin in bone and serum of normal rabbits and those with osteomyelitis.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6703678PubMed
6,436,291Comparison of fluorescence polarization immunoassay and bioassay of vancomycin.J Clin Microbiol1984https://conductscience.org/library/papers/6436291PubMed
6,386,852Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay.J Clin Microbiol1984https://conductscience.org/library/papers/6386852PubMed
6,357,070Evaluation of an automated fluorescence polarization immunoassay for vancomycin.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6357070PubMed
3,530,582Clinical pharmacokinetics of vancomycin.Clin Pharmacokinet1986https://conductscience.org/library/papers/3530582PubMed
2,952,062Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/2952062PubMed
2,354,591Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.Clin Pharmacokinet1990https://conductscience.org/library/papers/2354591PubMed
2,149,492Application of a modified bioassay for monitoring serum teicoplanin and vancomycin in febrile neutropenic patients.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2149492PubMed
718,158Safety of oral vancomycin in functionally anephric patients.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/718158PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/415661

GET https://conductscience.org/api/papers/v1/415661/authors